Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Nov;80(11):1625-1657.
doi: 10.1007/s00228-024-03736-z. Epub 2024 Aug 26.

Reference guides for the safe use of drugs during pregnancy: a systematic review and comparative analysis

Affiliations
Comparative Study

Reference guides for the safe use of drugs during pregnancy: a systematic review and comparative analysis

Xue-Feng Jiao et al. Eur J Clin Pharmacol. 2024 Nov.

Abstract

Purpose: To comprehensively evaluate and compare all the available reference guides for the safe use of drugs during pregnancy, with the goal of determining the scientificity and reliability of these reference guides.

Methods: We searched PubMed, EMbase, CNKI, Wanfang Database, and VIP database to comprehensively identify the available reference guides. Moreover, we selected 103 drugs based on relevant literatures, and compared the recommendations of each drug from different reference guides.

Results: A total of 14 available reference guides were identified. However, none of these reference guides assessed the risk of bias of original studies or the quality of current evidence. Seven reference guides adopted expert consensus method to formulate pregnancy recommendations, while the rest reference guides did not report the formation method. Moreover, 77.7% of the selected drugs had inconsistent recommendations among different reference guides. In addition, the referenced human and animal studies for the same drug differed among different reference guides.

Conclusion: Our results indicate that current reference guides for the safe use of drugs during pregnancy are less scientific and reliable, and there are considerable discrepancies in recommendations from different reference guides concerning drug use during pregnancy. The reasons for the discrepancies in recommendations include ① the literature search in most reference guides was not comprehensive, ② none of the available reference guides assessed the risk of bias of original studies or the quality of current evidence, and ③ the method adopted by current reference guides to formulate recommendations had obvious subjectivity and lacked of scientificity.

Keywords: Comparative analysis; Pregnancy; Recommendations; Reference guides; The safe use of drugs.

PubMed Disclaimer

References

    1. Zhang C, Zhang LL, Chen L (2012) Medications used in pregnancy: a systematic review. J Chin Pharm Sci 47(11):858–862
    1. Broussard CS, Frey MT, Hernandez-Diaz S, Greene MF, Chambers CD, Sahin L et al (2014) Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention–convened meeting. Am J Obstet Gynecol 211(3):208-214.e1 - DOI - PubMed - PMC
    1. Zhang C, Zhang LL, Wang XD, Liu D, Li JL, Xiao D (2016) A comparative study of risk classification systems for drug use during pregnancy. Chin Pharm J 51(3):234–238
    1. Feibus KB (2008) FDA’s proposed rule for pregnancy and lactation labeling: improving maternal child health through well-informed medicine use. J Med Toxicol 4(4):284–288 - DOI - PubMed - PMC
    1. Zhang C, Zhang LL, Zeng LN, Wang XD, Jiang HY (2020) A comparative study of different references to the fetal risk of drugs in pregnancy. Chin J Evid Based Med 20(7):6

LinkOut - more resources